395934003: Anthraquinone glycoside (substance)

SNOMED CT Concept\Substance\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Hydrocarbon\Aromatic hydrocarbon\Anthracene\Anthraquinone\Anthraquinone glycoside (substance)

\Ketone\Cyclic ketone\Quinone and/or quinone derivative (substance)\Quinone\Anthraquinone\Anthraquinone glycoside (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1469874015 Anthraquinone glycoside (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1489567013 Anthraquinone glycoside en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Anthraquinone glycoside (substance)	Is a	Anthraquinone	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Salicylic acid+anthraquinone glycosides 1%/0.5% oral paint	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anthraquinone glycoside (substance)	Inferred relationship	Some
Cascara (substance)	Is a	True	Anthraquinone glycoside (substance)	Inferred relationship	Some
Anthraquinone glycoside and salicylic acid only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Anthraquinone glycoside (substance)	Inferred relationship	Some	2
Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Anthraquinone glycoside (substance)	Inferred relationship	Some	2
Anthraquinone glycoside- and salicylic acid-containing product in oromucosal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Anthraquinone glycoside (substance)	Inferred relationship	Some	2
Product containing anthraquinone glycoside and salicylic acid (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Anthraquinone glycoside (substance)	Inferred relationship	Some	2
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Anthraquinone glycoside (substance)	Inferred relationship	Some	2
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Anthraquinone glycoside (substance)	Inferred relationship	Some	2

Reference Sets